During the past decade, Licking Memorial Hospital conducted 112 clinical trials. In the 10-year time frame, 112 clinical trials started and 106 clinical trials were completed, i.e. on average, 94.6% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 49 clinical trials were completed. i.e. 181.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Licking Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 129 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored and "GOG Foundation" with 13 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Licking Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 101 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Licking Memorial Hospital" are "Recurrent Breast Carcinoma" (12 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Lung Cancer AJCC v8" (10 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (9 trials). Many other conditions were trialed in "Licking Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Licking Memorial Hospital" are "Drug" (188 trials), "Other" (156 trials), "Biological" (103 trials), "Procedure" (54 trials) and "Radiation" (22 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (86 trials), "Quality-of-Life Assessment" (68 trials), "Questionnaire Administration" (36 trials), "Paclitaxel" (34 trials) and "Carboplatin" (32 trials). Other intervention names were less common.

The vast majority of trials in "Licking Memorial Hospital" are 180 trials for "All" genders, 57 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Licking Memorial Hospital". undefined are not yet recruiting, 47 are recruiting, 111 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Licking Memorial Hospital, 3 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Licking Memorial Hospital, 9 "Phase 1" clinical trials were conducted, 111 "Phase 2" clinical trials and 118 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".

Licking Memorial Hospital has several departments that took part in Clinical trials: "Licking Memorial Cancer Care Program at Licking Memorial Hospital" - 118 trials